[Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)].
D000328:Adult; D000368:Aged; D001007:Anxiety; D002230:Carbidopa / Q000627:therapeutic use; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D003863:Depression / Q000188:drug therapy*; D003891:Desipramine / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases; D002230:Carbidopa; D003891:Desipramine
Association L-dopa, désipramine et inhibiteur de la décarboxylase dans le traitement de la dépression.